Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

View the latest Equifax Inc. (EFX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

View and compare FIG,BMRN,HOOD,CRWV,NVDA,NVDX,AMD,URA,NUKZ,AMZN,AMZU,MSFT,GOOG,RTX,EFX,JAZZ on Yahoo Finance.

View and compare BWXT,BMRN,FIG,HOOD,CRWV,NVDA,NVDX,AMD,AMZN,AMZU,MSFT,GOOG,RTX,EFX,JAZZ on Yahoo Finance.

See the latest Fair Isaac Corp stock price (FICO:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

EFX-treated participants also exhibited improvements in markers of liver injury and whole-body metabolic health. “The HARMONY results published in The Lancet provide encouraging evidence of EFX’s ...